Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New phase 2 data boosts prospects for Alder's migraine drug
New phase 2 data boosts prospects for Alder's migraine drug
New phase 2 data boosts prospects for Alder's migraine drug
Submitted by
admin
on March 28, 2016 - 6:51pm
Source:
BioPharma Dive
News Tags:
migraines
Alder Biopharmaceuticals
ALD403
Headline:
New phase 2 data boosts prospects for Alder's migraine drug
Do Not Allow Advertisers to Use My Personal information
